{"id":45403,"date":"2025-10-31T15:00:07","date_gmt":"2025-10-31T07:00:07","guid":{"rendered":"https:\/\/flcube.com\/?p=45403"},"modified":"2025-10-31T15:00:08","modified_gmt":"2025-10-31T07:00:08","slug":"shanghai-bio%e2%80%91hearts-iberis-rdn-system-gains-uk-mhra-approval-expands-global-commercial-reach","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45403","title":{"rendered":"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach"},"content":{"rendered":"\n<p><strong>Shanghai Bio\u2011Heart Biological Technology Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2185:HKG\">HKG: 2185<\/a>) announced that its subsidiary, <strong>Shanghai AngioCare Medical Technology Co., Ltd.<\/strong>, has secured <strong>registration with the UK\u2019s Medicines and Healthcare products Regulatory Agency (MHRA)<\/strong> for the <strong>Iberis Multipolar Renal Denervation Catheter System (Iberis RDN System)<\/strong>. The system, the only RDN device globally cleared for both <strong>Transradial Approach (TRA)<\/strong> and <strong>Transfemoral Artery (TFA)<\/strong> access, is now positioned for broader commercialization across the European Union, Asia\u2011Pacific, and Latin America through a new partnership with <strong>Biosensors International Group, Ltd.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-highlights\"><strong>Key Highlights<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>MHRA Registration<\/strong> \u2013 The Iberis RDN System has met all UK regulatory requirements, enabling immediate availability to UK clinicians and patients.<\/li>\n\n\n\n<li><strong>Global Partnership<\/strong> \u2013 AngioCare and <strong>Biosensors<\/strong> have agreed to collaborate on commercialization across multiple regions, leveraging Biosensors\u2019 extensive global distribution network.<\/li>\n\n\n\n<li><strong>Dual\u2011Access Advantage<\/strong> \u2013 TRA offers a safer, more effective, and cost\u2011efficient approach to renal denervation; the Iberis system\u2019s unique dual\u2011access capability positions it as the only product that can meet diverse clinical preferences worldwide.<\/li>\n\n\n\n<li><strong>Regulatory Milestone<\/strong> \u2013 The device previously received a CE mark in 2016 (ATON) and now adds the UK MHRA endorsement, solidifying its status as a leading RDN solution.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-about-the-iberis-rdn-system\"><strong>About the Iberis RDN System<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Multipolar Catheter<\/strong> \u2013 Delivers precise, multi\u2011point renal nerve ablation in a single session.<\/li>\n\n\n\n<li><strong>Transradial &amp; Transfemoral Compatibility<\/strong> \u2013 Allows clinicians to choose the most appropriate vascular access based on patient anatomy and operator skill.<\/li>\n\n\n\n<li><strong>Clinical Efficacy<\/strong> \u2013 Early\u2011phase studies demonstrate durable blood\u2011pressure reductions and a favorable safety profile.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\"><strong>Strategic Implications<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Expansion<\/strong> \u2013 UK approval opens the door to the largest single\u2011market RDN demand in Europe, creating a launchpad for further EU, APAC, and LATAM penetration.<\/li>\n\n\n\n<li><strong>Competitive Edge<\/strong> \u2013 By offering both TRA and TFA, Iberis differentiates itself from competitors that support only one access route.<\/li>\n\n\n\n<li><strong>Revenue Growth<\/strong> \u2013 The partnership with Biosensors is expected to accelerate sales velocity and expand the system\u2019s global footprint.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2025103002302_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2025103002302_c.\"><\/object><a id=\"wp-block-file--media-756b6d27-dbde-435a-a841-2d46741f5c63\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2025103002302_c.pdf\">2025103002302_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2025103002302_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-756b6d27-dbde-435a-a841-2d46741f5c63\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Shanghai Bio\u2011Heart Biological Technology Co., Ltd. (HKG: 2185) announced that its subsidiary, Shanghai AngioCare Medical&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45412,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[3777,2607,2606],"class_list":["post-45403","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-angiocare-medical-technology","tag-bio-heart-biological-technology","tag-hkg-2185"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shanghai Bio\u2011Heart Biological Technology Co., Ltd. (HKG: 2185) announced that its subsidiary, Shanghai AngioCare Medical Technology Co., Ltd., has secured registration with the UK\u2019s Medicines and Healthcare products Regulatory Agency (MHRA) for the Iberis Multipolar Renal Denervation Catheter System (Iberis RDN System). The system, the only RDN device globally cleared for both Transradial Approach (TRA) and Transfemoral Artery (TFA) access, is now positioned for broader commercialization across the European Union, Asia\u2011Pacific, and Latin America through a new partnership with Biosensors International Group, Ltd.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45403\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach\" \/>\n<meta property=\"og:description\" content=\"Shanghai Bio\u2011Heart Biological Technology Co., Ltd. (HKG: 2185) announced that its subsidiary, Shanghai AngioCare Medical Technology Co., Ltd., has secured registration with the UK\u2019s Medicines and Healthcare products Regulatory Agency (MHRA) for the Iberis Multipolar Renal Denervation Catheter System (Iberis RDN System). The system, the only RDN device globally cleared for both Transradial Approach (TRA) and Transfemoral Artery (TFA) access, is now positioned for broader commercialization across the European Union, Asia\u2011Pacific, and Latin America through a new partnership with Biosensors International Group, Ltd.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45403\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-31T07:00:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-31T07:00:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3108.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach\",\"datePublished\":\"2025-10-31T07:00:07+00:00\",\"dateModified\":\"2025-10-31T07:00:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403\"},\"wordCount\":349,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3108.webp\",\"keywords\":[\"Angiocare Medical Technology\",\"Bio-heart Biological Technology\",\"HKG: 2185\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45403#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45403\",\"name\":\"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3108.webp\",\"datePublished\":\"2025-10-31T07:00:07+00:00\",\"dateModified\":\"2025-10-31T07:00:08+00:00\",\"description\":\"Shanghai Bio\u2011Heart Biological Technology Co., Ltd. (HKG: 2185) announced that its subsidiary, Shanghai AngioCare Medical Technology Co., Ltd., has secured registration with the UK\u2019s Medicines and Healthcare products Regulatory Agency (MHRA) for the Iberis Multipolar Renal Denervation Catheter System (Iberis RDN System). The system, the only RDN device globally cleared for both Transradial Approach (TRA) and Transfemoral Artery (TFA) access, is now positioned for broader commercialization across the European Union, Asia\u2011Pacific, and Latin America through a new partnership with Biosensors International Group, Ltd.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45403\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3108.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3108.webp\",\"width\":1080,\"height\":608,\"caption\":\"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45403#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach - Insight, China&#039;s Pharmaceutical Industry","description":"Shanghai Bio\u2011Heart Biological Technology Co., Ltd. (HKG: 2185) announced that its subsidiary, Shanghai AngioCare Medical Technology Co., Ltd., has secured registration with the UK\u2019s Medicines and Healthcare products Regulatory Agency (MHRA) for the Iberis Multipolar Renal Denervation Catheter System (Iberis RDN System). The system, the only RDN device globally cleared for both Transradial Approach (TRA) and Transfemoral Artery (TFA) access, is now positioned for broader commercialization across the European Union, Asia\u2011Pacific, and Latin America through a new partnership with Biosensors International Group, Ltd.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45403","og_locale":"en_US","og_type":"article","og_title":"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach","og_description":"Shanghai Bio\u2011Heart Biological Technology Co., Ltd. (HKG: 2185) announced that its subsidiary, Shanghai AngioCare Medical Technology Co., Ltd., has secured registration with the UK\u2019s Medicines and Healthcare products Regulatory Agency (MHRA) for the Iberis Multipolar Renal Denervation Catheter System (Iberis RDN System). The system, the only RDN device globally cleared for both Transradial Approach (TRA) and Transfemoral Artery (TFA) access, is now positioned for broader commercialization across the European Union, Asia\u2011Pacific, and Latin America through a new partnership with Biosensors International Group, Ltd.","og_url":"https:\/\/flcube.com\/?p=45403","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-31T07:00:07+00:00","article_modified_time":"2025-10-31T07:00:08+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3108.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45403#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45403"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach","datePublished":"2025-10-31T07:00:07+00:00","dateModified":"2025-10-31T07:00:08+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45403"},"wordCount":349,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45403#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3108.webp","keywords":["Angiocare Medical Technology","Bio-heart Biological Technology","HKG: 2185"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45403#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45403","url":"https:\/\/flcube.com\/?p=45403","name":"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45403#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45403#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3108.webp","datePublished":"2025-10-31T07:00:07+00:00","dateModified":"2025-10-31T07:00:08+00:00","description":"Shanghai Bio\u2011Heart Biological Technology Co., Ltd. (HKG: 2185) announced that its subsidiary, Shanghai AngioCare Medical Technology Co., Ltd., has secured registration with the UK\u2019s Medicines and Healthcare products Regulatory Agency (MHRA) for the Iberis Multipolar Renal Denervation Catheter System (Iberis RDN System). The system, the only RDN device globally cleared for both Transradial Approach (TRA) and Transfemoral Artery (TFA) access, is now positioned for broader commercialization across the European Union, Asia\u2011Pacific, and Latin America through a new partnership with Biosensors International Group, Ltd.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45403#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45403"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45403#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3108.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3108.webp","width":1080,"height":608,"caption":"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45403#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shanghai Bio\u2011Heart\u2019s Iberis RDN System Gains UK MHRA Approval, Expands Global Commercial Reach"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3108.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45403"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45403\/revisions"}],"predecessor-version":[{"id":45413,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45403\/revisions\/45413"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45412"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}